-
-
-
-
-
-
-
Beam Therapeutics Inc (BEAM) PT Raised to $47 at Leerink Partners
-
-
-
-
-
-
-
Canaccord Genuity Starts Beam Therapeutics Inc (BEAM) at Buy
-
-
-
-
-
-
-
UBS Starts Beam Therapeutics Inc (BEAM) at Neutral
-
-
-
-
-
-
-
Why public perception matters so much for biotech valuations
-
-
-
-
-
-
-
Verve Therapeutics takeover has 'positive readthrough' for gene editing space - BMO Capital
-
-
-
-
-
-
-
Beam Therapeutics Inc. (BEAM) 10K contracts of August 20 puts trade
-
-
-
-
-
-
-
Beam Therapeutics Inc (BEAM) PT Raised to $64 at Citi
-
416,805 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

